What Is MyoBalan? The 40:1 Myo-Inositol Formula for Women's Cycle Support Explained
Table of Contents
- Key Takeaways
- The science of inositol in women's health
- Myo-Inositol β the FSH sensitiser
- D-Chiro-Inositol β the insulin mediator
- Why the 40:1 ratio is critical
- CoQ10 and NAC β ovarian energy and antioxidant defence
- Folate 6-MTHF, Vitamin D3, and Zinc β the nutritional foundation
- Explore MyoBalan with BioEssentials
TL;DR:
- MyoBalan delivers the clinically validated 40:1 ratio of Myo-Inositol to D-Chiro-Inositol β the physiologically optimal proportion found in human follicular fluid β formulated specifically for women with cycle irregularity, PCOS, or hormonal imbalance.
- The formula is further supported by CoQ10 150mg for follicular energy, NAC 100mg for antioxidant and ovarian function, Folate as active 6-MTHF 600mcg, Zinc, and Vitamin D3 β addressing the complete hormonal and metabolic environment, not just inositol ratios alone.
- MyoBalan is designed for women who want a science-grounded, evidence-dosed approach to cycle support that goes well beyond single-ingredient inositol powders commonly sold for this purpose.
MyoBalan is a precision women's cycle support supplement built around the clinically established 40:1 ratio of Myo-Inositol to D-Chiro-Inositol (DCI) β the ratio shown in research to mirror the natural proportion in human follicular fluid and to most effectively support insulin signalling, FSH sensitivity, and oocyte quality. The formula extends beyond inositol alone, adding CoQ10 150mg, NAC 100mg, active Folate (6-MTHF) 600mcg, Vitamin D3 25mcg, and Zinc for a complete hormonal, metabolic, and reproductive support system.
Key Takeaways
| Point | Details |
|---|---|
| Inositol ratio | 40:1 Myo-Inositol : D-Chiro-Inositol β mirrors natural follicular fluid concentration |
| D-Chiro-Inositol dose | 22.5mg β precise amount to achieve 40:1 without exceeding physiological DCI levels |
| CoQ10 form | 150mg β energy substrate for oocyte mitochondrial function |
| NAC dose | 100mg N-Acetyl Cysteine β antioxidant, glutathione precursor, insulin sensitiser |
| Folate form | 600mcg as 6-MTHF β active methylfolate, pre-conception DNA integrity |
| Vitamin D3 | 25mcg (1,000 IU) β ovarian function, insulin sensitivity, anti-inflammatory |
The science of inositol in women's health
Inositol is a carbocyclic polyol naturally present in cell membranes, where it functions as a second messenger in insulin and FSH (follicle-stimulating hormone) signalling cascades. Two isomers are directly relevant to female reproductive health: Myo-Inositol (MI), which sensitises FSH receptors in granulosa cells and supports oocyte maturation, and D-Chiro-Inositol (DCI), which mediates insulin's effects on androgen synthesis and glycogen storage in reproductive tissues.
In women with PCOS and related conditions, the enzyme that converts MI to DCI is often overactive β depleting MI in follicular fluid and impairing the FSH signalling needed for normal follicle development. Supplementing with the correct ratio of MI to DCI has been the subject of intensive clinical research over the past two decades, with consistent findings supporting improvements in cycle regularity, ovulation rate, hormonal markers, and metabolic parameters.
Myo-Inositol β the FSH sensitiser
Myo-Inositol is the primary inositol isomer in human follicular fluid, present at approximately 100 times the concentration of DCI. Its principal role in reproductive medicine is to potentiate FSH (follicle-stimulating hormone) receptor signalling in granulosa cells β the cells that surround and nurture developing egg follicles. Adequate MI ensures that FSH signalling proceeds efficiently, supporting normal follicle growth, oocyte quality, and ovulation timing.
Clinical evidence on Myo-Inositol supplementation in women with PCOS is extensive and robust. Multiple randomised controlled trials and meta-analyses have demonstrated improvements in: menstrual cycle regularity, ovulation rate and spontaneous pregnancy rate, testosterone and LH levels, and insulin resistance markers including fasting insulin and HOMA-IR index.
D-Chiro-Inositol β the insulin mediator
D-Chiro-Inositol (DCI) mediates insulin's role in non-oxidative glucose metabolism in reproductive tissues and appears to regulate androgen synthesis via insulin-signalling pathways in the ovarian theca cells. Elevated insulin β a feature of insulin resistance common in PCOS β stimulates thecal androgen production through a DCI-independent pathway, leading to hyperandrogenism and anovulation. Providing DCI at the correct physiological concentration appears to improve insulin's downstream signalling without the adverse effects of excess DCI.
The key clinical insight is that excessive DCI β as seen in earlier studies using DCI alone at high doses β paradoxically worsens oocyte quality by depleting MI from follicular fluid. This is why the ratio, not the absolute dose, is the critical variable.
Why the 40:1 ratio is critical
The 40:1 MI:DCI ratio was established through analysis of the natural inositol concentration in human follicular fluid and validated in clinical studies by Italian researchers at the Sapienza University of Rome. Studies comparing different ratios have found that the 40:1 formulation consistently outperforms higher DCI proportions on measures of oocyte quality, fertilisation rate (in assisted reproduction), and ovarian response to FSH stimulation.
In MyoBalan, the 40:1 ratio is achieved by providing Myo-Inositol at the primary therapeutic dose with D-Chiro-Inositol at exactly 22.5mg β precisely calculated to maintain the ratio across the full daily dose. This precision is absent from products that use approximate or round-number DCI doses.
| Formula Type | MI:DCI Ratio | Outcome on Oocyte Quality |
|---|---|---|
| DCI alone (high dose) | 0:1 | Depletes follicular MI β impairs oocyte quality |
| MI alone | MI only | Effective but misses insulin-signalling synergy of DCI |
| 2:1 or other ratios | Non-physiological | Mixed results β DCI excess risk |
| 40:1 (MyoBalan) | Physiological | Best outcomes on oocyte quality and ovulation rate in trials |
CoQ10 and NAC β ovarian energy and antioxidant defence
Oocytes are among the largest and most metabolically demanding cells in the human body. Mitochondrial dysfunction in oocytes β reflected in declining CoQ10 levels with age β is a significant contributor to reduced oocyte quality, failed fertilisation, and early pregnancy loss. CoQ10 at 150mg supports the mitochondrial electron transport chain in granulosa and oocyte cells, providing the ATP energy required for the spindle assembly and chromosome segregation events of meiosis.
NAC (N-Acetyl Cysteine) at 100mg serves as a precursor to glutathione β the primary antioxidant defending the oocyte from oxidative damage. NAC has been independently studied in PCOS populations and has demonstrated insulin-sensitising effects comparable to metformin at therapeutic doses in some trials, as well as improvements in cycle regularity. Its combined antioxidant and insulin-sensitising properties make it a valuable complement to the inositol core of the formula.
Folate 6-MTHF, Vitamin D3, and Zinc β the nutritional foundation
Folate as 6-MTHF (methyltetrahydrofolate) at 600mcg provides the active, bioavailable form of folate that bypasses the MTHFR enzyme conversion β a gene variant affecting a significant proportion of women and reducing standard folic acid conversion efficiency by up to 70%. Adequate folate is required for DNA methylation and nucleotide synthesis during oocyte maturation and early embryonic development β making it indispensable in any pre-conception or reproductive support formula.
Vitamin D3 at 25mcg (1,000 IU) supports ovarian function via VDR (vitamin D receptor) expression in granulosa cells, insulin sensitivity, and the regulation of AMH (anti-Mullerian hormone) secretion. Vitamin D deficiency is highly prevalent in women with PCOS and is independently associated with worse metabolic and hormonal profiles. Zinc at the included dose supports androgen receptor regulation and is a cofactor for the aromatase enzyme that converts androgens to estrogens in granulosa cells.
Explore MyoBalan with BioEssentials
MyoBalan combines the gold-standard 40:1 inositol ratio with a complete supporting cast of ovarian energy, antioxidant defence, and micronutrient cofactors β making it one of the most clinically informed women's cycle support formulas available. Whether the concern is PCOS, cycle irregularity, hormonal imbalance, or pre-conception preparation, MyoBalan provides the full nutritional environment that the ovarian system requires.
MyoBalan by BioEssentials β 40:1 Myo-Inositol Women's Cycle Support
Frequently asked questions
Is MyoBalan specifically for women with PCOS?
MyoBalan's formulation is most directly supported by evidence in women with PCOS. However, its ingredients also benefit women without a PCOS diagnosis who experience cycle irregularity, hormonal imbalance, or sub-optimal ovarian function related to insulin resistance, stress, or nutritional deficiencies. The 40:1 inositol ratio is beneficial wherever follicular MI levels are depleted relative to DCI.
Can MyoBalan be taken pre-conception?
Yes. The inclusion of active Folate 6-MTHF at 600mcg makes MyoBalan suitable for pre-conception use β folate supplementation in the 12 weeks before conception is a standard recommendation for reducing neural tube defect risk. The CoQ10 content supports oocyte mitochondrial quality, and the inositol ratio supports ovulation regularity. Always consult a healthcare professional for personalised pre-conception guidance.
How does MyoBalan differ from standard inositol powders?
Most commercially available inositol products contain Myo-Inositol only, without the DCI component β missing the insulin-signalling synergy. Others use non-physiological ratios (e.g. 3.6:1 or 5:1). MyoBalan uses the 40:1 ratio established by clinical research as physiologically optimal, combined with CoQ10, NAC, 6-MTHF, D3, and Zinc β a level of completeness not found in powder-format inositol products.
How long does MyoBalan take to regulate cycles?
Clinical trials on Myo-Inositol supplementation in women with PCOS have reported improvements in cycle regularity within 3 to 6 months of consistent use. Ovulation rate improvements and hormonal marker changes (LH:FSH ratio, testosterone) typically appear within 3 months. Individual response varies depending on the severity of underlying hormonal disruption and lifestyle factors including diet and physical activity.
Why is 6-MTHF preferable to folic acid in MyoBalan?
Folic acid (the synthetic form of folate) requires conversion by the MTHFR enzyme to become biologically active. Approximately 40 to 60% of the population carries one or two copies of the common C677T MTHFR variant, which reduces this conversion by up to 70%. 6-MTHF (methyltetrahydrofolate) is the already-converted, active form β it is directly usable by the body regardless of MTHFR genotype, making it the superior choice in any reproductive health context where folate adequacy is critical.
Recommended
- How to choose the right magnesium supplement: the 5-form buyer's guide β BioEssentials
- How to stack magnesium: 5 BioEssentials formulas explained β BioEssentials
- How to choose a daily energy supplement: 5 criteria β BioEssentials
- How to choose a hair supplement: 5 criteria beyond biotin β BioEssentials
- How to choose an immunity mushroom supplement: 5 criteria β BioEssentials
Our research and formulas have been recognized by leading media outlets such as Marie Claire.
Scientific References
- Clinical evidence on Inositol efficacy and safety (PubMed)
- Mechanisms of action and bioavailability of Inositol (PMC)
- Evidence-based review: Inositol supplementation outcomes (PubMed)
These statements have not been evaluated by the Food and Drug Administration. BioEssentials products are food supplements intended to support general wellness and daily nutritional needs. They are not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare professional before starting any new supplement if you are pregnant, breastfeeding, taking medication, or managing a health condition.
